Patrick Bilbo
Geschäftsführer bei ORGANOGENESIS HOLDINGS INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Patrick Bilbo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORGANOGENESIS HOLDINGS INC. | Geschäftsführer | 01.01.2017 | - |
General Counsel | 01.01.1999 | 01.01.2017 | |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Geschäftsführer | 01.01.2017 | - |
General Counsel | 01.01.2017 | - |
Karriereverlauf von Patrick Bilbo
Ehemalige bekannte Positionen von Patrick Bilbo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | General Counsel | 01.01.1994 | 01.01.1998 |
STRYKER CORPORATION | Corporate Officer/Principal | - | - |
Ausbildung von Patrick Bilbo
Syracuse University | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Boston University Graduate School of Arts & Sciences | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
General Counsel | 3 |
Chief Operating Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
ORGANOGENESIS HOLDINGS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
- Börse
- Insiders
- Patrick Bilbo
- Erfahrung